We are happy to support Believe In A Cure with Grant funding to contribute towards their AAV Drug Refinement Study in FOXG1 mice. BIAC has contracted a company called Psychogenics and partnered with University of Massachusetts Medical School in research and development of this drug. The mission of the organization is to develop a treatment for a rare brain disease called FOXG1 syndrome which has links to Alzheimer’s, schizophrenia, and brain tumors. This syndrome prevents impacted kids from walking, talking, or doing anything independently while suffering from seizures, a sleep disorder, feeding difficulties, and more (many patients have died from the complexity of these issues). The second part of the mission is to provide support to impacted families.